Goodwin
Graham Defries
- Deals
- 2
- Latest
- Jul 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 2 deals
Often works with
- Gozde Guckaya 2 deals together
- Andrew Harrow 1 deal together
- Mike Grainger 1 deal together
- Danielle Swinnerton 1 deal together
- Morag Peberdy 1 deal together
- Sarah Jordan 1 deal together
- Vicky Ling 1 deal together
- Simone Waterbury 1 deal together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Jul 2026 | Memo Therapeutics | – | Ipsen | Acquisition | Legal adviser to Memo Therapeutics AG (target) | Announced | 231.1 | Biotech | Ipsen acquisition of Memo Therapeutics |
| Apr 2026 | Tubulis | EQT Life Sciences (LSP 7 fund) | Gilead Sciences | Acquisition | Legal adviser to Tubulis (target) | Announced | 3,150.0 | Biotech+2 | Gilead Sciences acquisition of Tubulis |
Deals where Graham Defries is named on the firm's deal team, by the firm or the press.